Dr. Thomas Burris Named Recipient of the Louis S. Goodman and Alfred Gilman Award in Receptor Pharmacology (UF Pharmacy)
UF researcher Thomas P. Burris, Ph.D., has been selected as the recipient of the Louis S. Goodman and Alfred Gilman Award in Receptor Pharmacology, one of the most distinguished honors in the field of pharmacology.
UF researchers honored with awards during 2026 Celebration of Research (Doctor Gator)
UF inventors were recognized at the College of Medicine’s 2026 Celebration of Research for their outstanding achievements.
LightPath Technologies Receives $9.6 Million Purchase Order for Cooled Infrared Cameras From Existing Defense Customer (PR Newswire)
UF startup LightPath Technologies, Inc., announced that it has secured a $9.6 million purchase order for cooled infrared cameras from an existing defense customer for use in defense and security applications, with deliveries expected throughout calendar year 2026.
UF Researchers Identify Mental Health Effects of AI-Driven Job Insecurity (UF News)
UF researchers have introduced “AI replacement dysfunction” (AIRD), a new clinical model published in Cureus to help health care providers identify and address the psychological stress workers may experience as AI reshapes the workplace.
Jesse Dallery Aims To Make Evidence-Based Treatment Accessible to Everyone (UF Health)
UF researcher Jesse Dallery applies his clinical expertise to develop technology-based interventions that promote healthier behaviors, including helping people quit tobacco use.
Tech Tuesday: Tech Company Transforms Traditional Ultrasound Scans Into Immersive 3D Experience (WCJB TV20)
In this week’s Tech Tuesday, UF Innovate highlights Quency, a company that transforms traditional ultrasound scans into an immersive 3D experience.
Oragenics Targets Projected $9 Billion Market by Advancing First and Only Clinical-Stage Concussion and Mild Traumatic Brain Injury Therapy (Globe Newswire)
UF Innovate | Accelerate graduate Oragenics, Inc. outlined its 2026 milestones as it advances ONP-002, a novel intranasal neurosteroid in clinical development for concussion and mild traumatic brain injury.
Solid Biosciences Announces Positive Feedback From Type C Meeting With FDA for SGT-003 Gene Therapy for Duchenne Muscular Dystrophy (Globe Newswire)
Solid Biosciences Inc., which acquired UF startup AavantiBio, announced a positive regulatory update from its recent Type C meeting with the U.S. FDA that supports the continued advancement of SGT-003 as a potential treatment for Duchenne muscular dystrophy.
UF College of Medicine Launches AI in Biomedical and Health Sciences Master’s Program (Doctor Gator)
With workforce preparedness top of mind, the University of Florida College of Medicine is debuting the Artificial Intelligence in Biomedical and Health Sciences, or AIBHS, program this fall — one of a few graduate programs of its kind in the nation.
Meet UF’s Nicholas Rudawski: YouTube Star in Electron Microscopy Education (UF HWCE)
Nicholas Rudawski, Ph.D., an electron microscopy expert at the University of Florida’s Nanoscale Research Facility (NRF), is helping students and researchers from around the world use electron microscopes and understand electron microscopy, one video at a time.